Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores

New Rochester and Syracuse locations will expand the company’s retail footprint to six dispensaries in New York and 148 nationwide.

Rob Karlic | Curaleaf

Rob Karlic | Curaleaf

STAMFORD, Conn., July 25, 2024 – PRESS RELEASE – Curaleaf Holdings Inc., a leading international provider of consumer cannabis products, announced it will open two new medical dispensaries and will begin co-located adult-use sales at two existing medical dispensaries in New York.

Curaleaf Rochester, located at 532 Chili Ave., Rochester, N.Y., will open July 25, and Curaleaf Syracuse, located at 4141 South Salina St., Syracuse, N.Y., will open in the coming weeks, pending regulatory approval. On July 20, co-located adult-use sales began at the existing medical store, Curaleaf Plattsburgh, and Curaleaf Forest Hills will begin co-located adult-use sales on July 26.

This expansion will increase the company's retail footprint in the Empire State to six total stores, with three co-located adult-use and medical locations, and three medical-only locations.

In celebration of the new store openings, Curaleaf Rochester will host a grand opening event on July 26, featuring live local music, food trucks and prizes. Curaleaf Syracuse will host its grand opening at a later date, pending regulatory approval.

Each new medical dispensary is staffed with a team of three full-time pharmacists to assist patients in exploring the company’s expansive collection of brands and products, including Grassroots indoor-grown flower, Select's full lineup of vape and edible products, including the new Select Fruit STIQ All-In-One Vape, JAMS edibles, B NOBLE, and New York's best-selling all-in-one 2-gram vape, Select BRIQ. 

Adult-use consumers and medical patients can maximize their retail experience by enrolling in Curaleaf Rewards to earn special offers and discounts. During each visit, Curaleaf's team of knowledgeable staff members will be available to provide assistance, answer questions and guide consumers through the wide world of adult-use cannabis.

“We thank the Office of Cannabis Management for approving us to expand our operations to ensure even more New York patients and customers have access to licensed, tested cannabis across the state,” Curaleaf CEO Matt Darin said. “From Rochester to Forest Hills, our team members are eager to welcome the newest members of our cannabis community while continuing to provide medical patients with the high-quality service and products they deserve. This is an exciting step forward for our retail operations in New York, which we consider to be a key founding state for the Curaleaf brand.”

Curaleaf remains steadfast in its commitment to uplifting the medical patients and adult-use consumers of New York through health, wellness and community. At each adult-use location, Curaleaf will continue to prioritize medical patients with access to dedicated staff members, industry-leading product offerings and other amenities designed to provide a premier retail experience.

For more information on Curaleaf's locations, patient resources, delivery program and products in New York, visit https://curaleaf.com/dispensary/new-york.